FDA Issues Warning for Some Juvenile Rheumatoid Arthritis Drugs - TNF Blockers May Boost Kids' Cancer Risk
Links shared publicly online about this topic.
- 1,828total visits
FDA Issues Warning for Some Juvenile Rheumatoid Arthritis Drugs - TNF Blockers May Boost Kids' Cancer Risk
The US Food and Drug Administration (FDA)announced that TNF blockers, a class of drugs commonly used to treat juvenile rheumatoid arthritis and ankylosing spondylitis, may increase the risk of cancer in children and young adults.
View full resource at spineuniverse.com
Tags: Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Juvenile Rheumatoid Arthritis, Spondyloarthropathy, Ankylosing Spondylitis, Drug, Children's Health, FDA
Most Recently Shared on August 12, 2009 at 8:16 pm By:
FDA warns about TNF blockers for juvenile rheumatoid arthritis--but how concerned should you be? http://bit.ly/JhWnp
Advertisement
